Detalles de la búsqueda
1.
Effects of pro-depressant and immunomodulatory drugs on biases in decision-making in the rat judgement bias task.
Eur J Neurosci
; 55(9-10): 2955-2970, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502040
2.
Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders.
Brain Behav Immun
; 88: 461-470, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32278850
3.
GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species.
J Pharmacol Exp Ther
; 350(1): 153-63, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24784567
4.
Rapid-acting antidepressant drugs modulate affective bias in rats.
Sci Transl Med
; 16(729): eadi2403, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38198569
5.
Investigating neuropsychological and reward-related deficits in a chronic corticosterone-induced model of depression.
Psychoneuroendocrinology
; 147: 105953, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36334546
6.
Dopamine modulating agents alter individual subdomains of motivation-related behavior assessed by touchscreen procedures.
Neuropharmacology
; 211: 109056, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35398102
7.
The characterization of a novel V1b antagonist lead series.
Bioorg Med Chem Lett
; 21(1): 92-6, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21146408
8.
Symptomatic and preventive effects of the novel phosphodiesterase-9 inhibitor BI 409306 in an immune-mediated model of neurodevelopmental disorders.
Neuropsychopharmacology
; 46(8): 1526-1534, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33941860
9.
Pyrrolo[1,2-a]pyrazine and pyrazolo[1,5-a]pyrazine: novel, potent, and selective series of Vasopressin 1b receptor antagonists.
Bioorg Med Chem Lett
; 20(17): 5044-9, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20674355
10.
5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3.
Bioorg Med Chem Lett
; 20(23): 7092-6, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20951584
11.
Whole-brain signatures of functional connectivity after bidirectional modulation of the dopaminergic system in mice.
Neuropharmacology
; 178: 108246, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32771528
12.
Antimanic Efficacy of a Novel Kv3 Potassium Channel Modulator.
Neuropsychopharmacology
; 43(2): 435-444, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857068
13.
SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test.
Neuropsychopharmacology
; 32(10): 2163-72, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17356576
14.
Social defeat-induced contextual conditioning differentially imprints behavioral and adrenal reactivity: a time-course study in the rat.
Physiol Behav
; 92(4): 734-40, 2007 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-17707870
15.
Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Neuropharmacology
; 50(8): 975-83, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16581092
16.
Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
Peptides
; 27(12): 3202-7, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16959374
17.
Single exposure to social defeat increases corticotropin-releasing factor and glucocorticoid receptor mRNA expression in rat hippocampus.
Brain Res
; 1067(1): 25-35, 2006 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-16360122
18.
Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.
Br J Pharmacol
; 146(5): 744-51, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16158071
19.
Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.
Behav Brain Res
; 158(1): 123-32, 2005 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-15680200
20.
Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment.
Brain Res
; 1000(1-2): 148-55, 2004 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-15053962